Posted by admin on Aug 17th, 2022
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. reduced its stake in Surgalign Holdings, Inc. (NASDAQ:SRGA – Get Rating) by 3.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,187,918 shares of the company’s stock after selling 109,004 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. owned 1.60% of Surgalign worth $970,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the stock. HighTower Advisors LLC boosted its stake in shares of Surgalign by 59.6% during the fourth quarter. HighTower Advisors LLC now owns 803,500 shares of the company’s stock valued at $576,000 after purchasing an additional 300,000 shares in the last quarter. Waypoint Capital Advisors LLC purchased a new stake in Surgalign during the first quarter valued at approximately $40,000. Rafferty Asset Management LLC purchased a new stake in Surgalign during the fourth quarter valued at approximately $43,000. Global Trust Asset Management LLC lifted its position in Surgalign by 49.5% during the first quarter. Global Trust Asset Management LLC now owns 136,000 shares of the company’s stock valued at $41,000 after acquiring an additional 45,000 shares during the last quarter. Finally, First Eagle Investment Management LLC lifted its position in Surgalign by 26.5% during the fourth quarter. First Eagle Investment Management LLC now owns 95,504 shares of the company’s stock valued at $68,000 after acquiring an additional 20,000 shares during the last quarter. 28.35% of the stock is currently owned by institutional investors.
NASDAQ:SRGA opened at $4.47 on Wednesday. Surgalign Holdings, Inc. has a 52 week low of $2.95 and a 52 week high of $48.60. The firm has a 50 day moving average of $3.72 and a 200 day moving average of $8.11. The company has a quick ratio of 1.65, a current ratio of 2.33 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $30.16 million, a price-to-earnings ratio of -0.36 and a beta of 2.17.
Surgalign Holdings, Inc, a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine.
Receive News & Ratings for Surgalign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgalign and related companies with MarketBeat.com's FREE daily email newsletter.
M&T Bank Corp Purchases 405 Shares of Carvana Co. (NYSE:CVNA)
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Purchases 7,900 Shares of I-Mab (NASDAQ:IMAB)